Isabelle Treilleux

Université de Lyon

Affiliated withUniversité de Lyon Centre de Recherche en Cancérologie de Lyon Centre Leon Bérard

Research Area

Biography

Isabelle Treilleux has not added Biography.
If you are Isabelle Treilleux and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2022

Other Publications

Article	Year
Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 18353983	2008
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer. Journal of molecular endocrinology\| PubMed ID: 18984771	2009
Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis. Oncoimmunology\| PubMed ID: 22737622	2012
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer research\| PubMed ID: 22836755	2012
Activation of rapid oestrogen signalling in aggressive human breast cancers. EMBO molecular medicine\| PubMed ID: 23065768	2012
Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells. International journal of cancer\| PubMed ID: 23389942	2013
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment. Cancer research\| PubMed ID: 23722543	2013
Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network. Gynecologic oncology\| PubMed ID: 24157616	2014
Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death. EMBO molecular medicine\| PubMed ID: 24293316	2013
LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancer. International journal of cancer\| PubMed ID: 24615515	2014
Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institution. American journal of surgery\| PubMed ID: 24680949	2014
17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1. Carcinogenesis\| PubMed ID: 25823895	2015
Role of JMJD6 in Breast Tumourigenesis. PloS one\| PubMed ID: 25951181	2015
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Histopathology\| PubMed ID: 26033501	2016
TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. BMC cancer\| PubMed ID: 26040677	2015
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers. Nature communications\| PubMed ID: 27406316	2016
Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4. Oncotarget\| PubMed ID: 28423606	2017
Non-canonical NOTCH3 signalling limits tumour angiogenesis. Nature communications\| PubMed ID: 28719575	2017
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRAS-driven Pancreatic Tumorigenesis. Cellular and molecular gastroenterology and hepatology\| PubMed ID: 28752115	2017
Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer. Scientific reports\| PubMed ID: 29743633	2018
Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer. International journal of molecular sciences\| PubMed ID: 31195751	2019
Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1. Cells\| PubMed ID: 32290274	2020
ERα-36 regulates progesterone receptor activity in breast cancer. Breast cancer research : BCR\| PubMed ID: 32429997	2020
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 33578357	2021
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant. Breast cancer research : BCR\| PubMed ID: 34020697	2021
A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha Interaction. Journal of inflammation research\| PubMed ID: 34045885	2021
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes. Breast cancer research and treatment\| PubMed ID: 34561764	2021
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial. Cancers\| PubMed ID: 35267497	2022
Frequency of Asbestos Exposure and Histological Subtype of Ovarian Carcinoma. International journal of environmental research and public health\| PubMed ID: 35564776	2022
NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells. Aging cell\| PubMed ID: 35653631	2022
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration. Neurology(R) neuroimmunology & neuroinflammation\| PubMed ID: 35821104	2022